In contrast to the Th1 and Th17 subtypes, Th2 effector cells that are induced by IL-4 and produce IL-4, IL-5, IL-10, and IL-13, have been associated with inflammation reduction and improvement of symptoms in MS patients [41]. Here, IL4 is linked to myeloid sarcoma.